This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Equisetum arvense top is an ingredient in supplements for hair and nail health.

Generic Name
Equisetum arvense top
DrugBank Accession Number
DB14349
Background

Equisetum arvense top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Approved, Experimental
Synonyms
  • Bottlebrush Top
  • Common Horsetail Top
  • Equisetum
  • Equisetum Arvense
  • Equisetum Arvense Sterile Top
  • Equisetum Arvense Top Extract
  • Equisetum Arvense Vegetative Shoot
  • Equisetum Arvense Vegetative Top
  • Equisetum Calderi Top
  • Extract of the Sterile Caules of Equisetum Arvense
  • Field Horsetail Top
  • Foxtail-rush Top
  • Horesetail-fern Top
  • Horse-pipes Top
  • Horsetail (Equisetum Arvense) Extract
  • Meadow-pine Top
  • Pine-grass Top
  • Scouring Rush Top
  • Shave Grass Top
  • Shavetail Grass Top
  • Snake-grass Top
  • Western Horsetail Top

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
BABOR Cleansing Gel and TonicGel0.4 mL/200mLTopicalBabor Cosmetics America, Corp.2006-03-152017-02-15US flag
R.R. SiliconTablet10 mgOralAbundance Naturally Ltd1999-02-022005-06-28Canada flag
Salus Horsetail TctLiquid2 g / 50 mLOralSalus Haus1984-12-312003-07-24Canada flag
Silica Aqueous Extract 500mgCapsule500 mgOralWn Pharmaceuticals Ltd.1998-09-142006-08-08Canada flag
Vegetal SilicaTablet1000 mg / tabOralVita Health Products Inc1999-11-302002-07-31Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Osteo FactorsEquisetum arvense top (0.25 mg) + Ascorbic acid (25 mg) + Calcium (150 mg) + Cholecalciferol (100 unit) + Magnesium (75 mg) + Manganese (2 mg) + Pyridoxine hydrochloride (5 mg) + Zinc (3 mg)CapsuleOralNatural Factors Nutritional Products Ltd.2000-08-242005-08-15Canada flag
Osteo FormulaEquisetum arvense top (3.5 mg / tab) + Calcium (200 mg / tab) + Calcium ascorbate (100 mg / tab) + Copper (1 mg / tab) + Folic acid (0.1 mg / tab) + Magnesium (100 mg / tab) + Manganese (1 mg / tab) + Pyridoxine (5 mg / tab) + Vitamin D (100 unit / tab) + Zinc (10 mg / tab)TabletOralVita Health Products Inc2000-03-012002-07-31Canada flag
Osteo FormulaEquisetum arvense top (3.5 mg) + Calcium (200 mg) + Calcium ascorbate (100 mg) + Cholecalciferol (100 unit) + Copper (1 mg) + Folic acid (0.1 mg) + Magnesium (100 mg) + Manganese (1 mg) + Pyridoxine hydrochloride (5 mg) + Zinc (10 mg)TabletOralWn Pharmaceuticals Ltd.2002-06-122006-08-08Canada flag
Osteo RegimeEquisetum arvense top (.25 mg) + Ascorbic acid (25 mg) + Calcium (150 mg) + Cholecalciferol (100 unit) + Magnesium (75 mg) + Manganese (2 mg) + Pyridoxine hydrochloride (5 mg) + Zinc (3 mg)CapsuleOralRegime Industries Ltd.2003-06-162009-07-17Canada flag
Osteo-forceEquisetum arvense top (5 mg / cap) + Ascorbic acid (25 mg / cap) + Calcium (150 mg / cap) + Cholecalciferol (50 unit / cap) + Cyanocobalamin (2.5 mcg / cap) + Folic acid (0.1 mg / cap) + Magnesium (75 mg / cap) + Manganese (5 mg / cap) + Nicotinamide (5 mg / cap) + Pantothenic acid (2.5 mg / cap) + Potassium (25 mg / cap) + Pyridoxine hydrochloride (5 mg / cap) + Riboflavin (2.5 mg / cap) + Thiamine hydrochloride (2.5 mg / cap) + Zinc (5 mg / cap)CapsuleOralPrairie Naturals1997-10-172004-10-07Canada flag
Vegetal Silica 5:1Equisetum arvense top (500 mg / cap) + Silicon (10 mg / cap)CapsuleOralNutravite Pharmaceuticals Inc.1997-08-052001-07-13Canada flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
BABOR Cleansing Gel and TonicEquisetum arvense top (0.4 mL/200mL)GelTopicalBabor Cosmetics America, Corp.2006-03-152017-02-15US flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
1DP6Y6B65Z
CAS number
Not Available

References

General References
  1. NPRA: Evelle (Ascorbic acid, Bilberry, Biotin, Equisetum arvense top, Marine collagen, soluble, Maritime pine extract, Selenium, Tomato, Vitamin E, Zinc) Oral Tablet [Link]
RxNav
1306235

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelTopical0.4 mL/200mL
TabletOral
TabletOral10 mg
LiquidOral2 g / 50 mL
CapsuleOral500 mg
TabletOral1000 mg / tab
CapsuleOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 17:13 / Updated at August 17, 2021 04:16